EIGR insider filings

Eiger BioPharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-02. Screen EIGR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EIGR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Eiger BioPharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2023-11-024KAYNE RICHARD A — 10% ownerPurchase (P): 11,987 @ $0.26 · Purchase (P): 12,345 @ $0.26 · Purchase (P): 130,509 @ $0.24 · Purchase (P): 100,000 @ $0.28 · Purchase (P): 23,398 @ $0.30EDGAR
2023-11-024KAWAS LEEN — 10% ownerPurchase (P): 11,987 @ $0.26 · Purchase (P): 12,345 @ $0.26EDGAR
2023-09-054Choong Ingrid — Chief Business OfficerGrant/award (A): 54,000 (derivative) @ $0EDGAR
2023-07-064Apelian David — CEO, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2023-05-024Vollins James — General CounselGrant/award (A): 120,000 (derivative) @ $0EDGAR
2023-03-214Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerSale (S): 2,520 @ $1.07 · Sale (S): 1,875 @ $1.07EDGAR
2023-03-034Sachdev Amit — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Loh Evan — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Murray Christine — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Glenn Jeffrey S — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Sablich Kim — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Kelly-Croswell Lisa — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2023-03-034Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerGrant/award (A): 98,000 (derivative) @ $0EDGAR
2023-03-034Dietz Thomas John — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-02-024Apelian David — Interim CEO, DirectorGrant/award (A): 170,000 (derivative) @ $0EDGAR
2023-01-304Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerGrant/award (A): 31,500 (derivative) @ $0EDGAR
2023-01-304Atkisson Erik — GC & Chief Compliance OfficerGrant/award (A): 26,750 (derivative) @ $0EDGAR
2023-01-254Dietz Thomas John — DirectorPurchase (P): 50,000 @ $1.43EDGAR
2023-01-034Murray Christine — DirectorSale (S): 5,000 @ $1.22EDGAR
2022-12-274Dietz Thomas John — DirectorSale (S): 22,500 @ $1.17EDGAR
2022-12-274Glenn Jeffrey S — DirectorPurchase (P): 100,000 @ $1.28EDGAR
2022-08-184Apelian David — DirectorSale (S): 5,000 @ $9.81EDGAR
2022-07-194Kelly-Croswell Lisa — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-03-144Ryali Sriram — Chief Financial OfficerSale (S): 2,266 @ $5.60EDGAR
2022-03-144Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerSale (S): 1,657 @ $5.60EDGAR
2022-03-114Sachdev Amit — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-114Sablich Kim — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-114Ryali Sriram — Chief Financial OfficerGrant/award (A): 24,000 @ $0 · Grant/award (A): 143,000 (derivative) @ $0EDGAR
2022-03-114Murray Christine — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-114Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerGrant/award (A): 16,000 @ $0 · Grant/award (A): 98,000 (derivative) @ $0EDGAR
2022-03-114Glenn Jeffrey S — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-114Loh Evan — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-114Dietz Thomas John — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2022-03-114Cory David A — President and CEO, DirectorGrant/award (A): 47,000 @ $0 · Grant/award (A): 281,000 (derivative) @ $0EDGAR
2022-03-114Atkisson Erik — GC & Chief Compliance OfficerGrant/award (A): 6,000 @ $0 · Grant/award (A): 38,000 (derivative) @ $0EDGAR
2022-03-114Apelian David — DirectorGrant/award (A): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-01-114Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerSale (S): 1,560 @ $4.95EDGAR
2021-10-014Atkisson Erik — GC & Chief Compliance OfficerGrant/award (A): 180,000 (derivative) @ $0EDGAR
2021-07-304Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerGrant/award (A): 17,500 (derivative) @ $0EDGAR
2021-07-304Cory David A — President and CEO, DirectorGrant/award (A): 48,750 (derivative) @ $0EDGAR
2021-07-304Ryali Sriram — Chief Financial OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-05-114Ryali Sriram — Chief Financial OfficerGrant/award (A): 87,000 (derivative) @ $0EDGAR
2021-04-234Sablich Kim — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-04-124Dietz Thomas John — DirectorPurchase (P): 1,500 @ $8.48 · Purchase (P): 1,000 @ $8.50EDGAR
2021-03-154Mayer Eldon C. III — Ex VP & Chief Commerc. OfficerGrant/award (A): 11,875 @ $0 · Grant/award (A): 71,250 (derivative) @ $0EDGAR
2021-03-154Loh Evan — DirectorGrant/award (A): 5,000 @ $0 · Sale (S): 2,000 @ $10.14 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-03-154Glenn Jeffrey S — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-03-154Dietz Thomas John — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-03-154Cory David A — President and CEO, DirectorGrant/award (A): 47,000 @ $0 · Grant/award (A): 281,000 (derivative) @ $0EDGAR
2021-03-154Apelian David — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR

Recent 8-K events — Eiger BioPharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-10-018-K1.03 — Bankruptcy or Receivership
3.03 — Material Modification to Rights of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-098-K1.03 — Bankruptcy or Receivership
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-048-K2.01 — Completion of Acquisition or Disposition of AssetsEDGAR
2024-09-038-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-028-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-108-K2.01 — Completion of Acquisition or Disposition of AssetsEDGAR
2024-07-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-218-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EIGR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs